1. Alzheimer A (1907): Über eine eigenartige Erkrankung der Hirnrinde. Allgem Zeit Psychiat Psych-Gerich Med 64: 146–148.
2. Chui HC, Lyness S, Sobel E and Schneider LS (1992): Prognostic implications of symptomatic behaviors in Alzheimer’s disease. In: Heterogeneity of Alzheimer’s Disease, Boller F et al., eds. Berlin: Springer-Verlag, pp. 12–23.
3. Dehlin O, Hedenrud B, Jansson P and Norgard J (1985): A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia. Acta Psychiatry Scand 71: 190–196.
4. Friedhoff AJ (1994): Consensus development conference statement. In: Diagnosis and Treatment of Depression in the Elderly: Proceedings of the NIH Consensus Development Conference. Schneider LS, Reynolds CF, Lebowitz B and Friedhoff A, eds. Washington: American Psychiatric Press, pp. 491–511.
5. Hebenstreit GF, Baumhackl U, Chan-Palay V et al. (1991): The treatment of depression in geriatric depressed and demented patients by moclobemide. Fifth Congress of the International Psychogeriatric Association. Rome, Italy.